These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31821699)
1. Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway. Chen S; Zhou Q; Guo Z; Wang Y; Wang L; Liu X; Lu M; Ju L; Xiao Y; Wang X J Cell Mol Med; 2020 Jan; 24(2):1804-1821. PubMed ID: 31821699 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia. Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969 [TBL] [Abstract][Full Text] [Related]
3. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116 [TBL] [Abstract][Full Text] [Related]
5. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines. Wu G; Lin N; Xu L; Liu B; Feitelson MA BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372 [TBL] [Abstract][Full Text] [Related]
6. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells. Beke L; Kig C; Linders JT; Boens S; Boeckx A; van Heerde E; Parade M; De Bondt A; Van den Wyngaert I; Bashir T; Ogata S; Meerpoel L; Van Eynde A; Johnson CN; Beullens M; Brehmer D; Bollen M Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26431963 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant. Simon M; Mesmar F; Helguero L; Williams C PLoS One; 2017; 12(2):e0172832. PubMed ID: 28235006 [TBL] [Abstract][Full Text] [Related]
8. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G; Besnard E; Fisher D; Piette J; Dulić V Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626 [TBL] [Abstract][Full Text] [Related]
9. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021 [TBL] [Abstract][Full Text] [Related]
10. Sterigmatocystin-induced DNA damage triggers G2 arrest via an ATM/p53-related pathway in human gastric epithelium GES-1 cells in vitro. Zhang D; Cui Y; Shen H; Xing L; Cui J; Wang J; Zhang X PLoS One; 2013; 8(5):e65044. PubMed ID: 23705030 [TBL] [Abstract][Full Text] [Related]
11. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662 [TBL] [Abstract][Full Text] [Related]
12. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050 [TBL] [Abstract][Full Text] [Related]
13. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin. Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537 [TBL] [Abstract][Full Text] [Related]
14. MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells. Kohler RS; Kettelhack H; Knipprath-Mészaros AM; Fedier A; Schoetzau A; Jacob F; Heinzelmann-Schwarz V Gynecol Oncol; 2017 Apr; 145(1):159-166. PubMed ID: 28214016 [TBL] [Abstract][Full Text] [Related]
15. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway. Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073 [TBL] [Abstract][Full Text] [Related]
16. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer. Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801 [TBL] [Abstract][Full Text] [Related]
17. Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways. Gaul L; Mandl-Weber S; Baumann P; Emmerich B; Schmidmaier R J Cancer Res Clin Oncol; 2008 Feb; 134(2):245-53. PubMed ID: 17653574 [TBL] [Abstract][Full Text] [Related]
18. Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice. Luo Q; Guo H; Kuang P; Cui H; Deng H; Liu H; Lu Y; Wei Q; Chen L; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L Cell Physiol Biochem; 2018; 51(5):2421-2433. PubMed ID: 30537743 [TBL] [Abstract][Full Text] [Related]
19. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma. Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway. Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]